Device Trial Radar · NCT07283861
Axoguard HA Plus Nerve Protector to Reduce Post-operative Neck and Shoulder Dysfunction in Patients Undergoing Neck Dissection
Last checked: Nov 20, 2026Latest source record: May 12, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
90
Planned (sponsor's estimate)
Start
Dec 9, 2025
Primary completion
Jan 2027
Study completion Jan 2028
Sponsor
- Lead sponsor
- Matthew SpectorAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- Axogen Corporation
- First posted
- Dec 16, 2025
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
In this prospective study, patients with head and neck cancers undergoing neck dissection will have the nerve to the shoulder wrapped with the Axoguard HA+ Nerve Protector at time of surgery. In these patients, the presence and severity of neck and shoulder dysfunction on the operated side will be assessed approximately twelve months post-operatively. The investigators hypothesize that shoulder nerve wrapping with the Axoguard HA+ Nerve Protector will lead to clinically meaningful improvement of shoulder function.
Conditions
- Head and Neck Cancer
- Neck Dissection
Interventions
Spinal Accessory Nerve Protection utilizing Axoguard HA+Device
Nerve protection utilizing a nerve wrap.
Primary outcomes
What the sponsor says the trial is designed to measure.
- One year neck and shoulder dysfunction as assessed by the neck dissection impairment indexTime frame: one year
Locations
1 site in 1 country. Site status is shown where the registry gives one.
UPMC Presbyterian Shadyside
Pittsburgh, Pennsylvania
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.